Patient's TeleMonitoring With Amyotrophic Lateral Sclerosis Treated by Non Invasive Ventilation at Home.

NCT ID: NCT04797845

Last Updated: 2024-06-17

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 33 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2021-04-12
• Study Completion Date: 2023-09-18

Brief Summary

Single-center, prospective pilot study on patients with amyotrophic lateral sclerosis fitted with noninvasive ventilation. The objective is to assess the satisfaction of remote monitoring of patients on non-invasive ventilation after 12 months.

Detailed Description

The non invasive ventilation is one of treatments used during the amyotrophic lateral sclerosis when patients have a chronic respiratory failure with alveolar hypoventilation signs. It is demonstrated to improve quality of life and prognosis of the disease. These patients, often severely disabled, generally have a negative experience of repeated hospitalizations. Despite everything, medical and paramedical monitoring is necessary, especially when they are fitted with non invasive ventilation (NIV). A quarterly reassessment is recommended . The possibilities of telemonitoring at home have grown considerably in recent years. In addition, the fans are currently able to remotely transfer a certain amount of data to the service provider, making remote monitoring feasible.Our project therefore aims to assess the feasibility of remote monitoring of patients with Amyotrophic Lateral Sclerosis (ALS) fitted with non invasive ventilation (NIV) through the assessment of their satisfaction, using both medical data and data provided by the ventilator. It is a single-center, prospective pilot study on 30 patients with amyotrophic lateral sclerosis fitted with noninvasive ventilation. Patients will benefit from a quarterly teleconsultation to assess the study criteria through questionnaires during 12 months. Ventilation machines make it possible to carry out remote monitoring, with the help of healthcare providers.

Conditions

Amyotrophic Lateral Sclerosis; Noninvasive Ventilation

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: OTHER
• Blinding Strategy: NONE

Study Groups

telemonitoring of non invasive ventilation at home

Patients will benefit from a quarterly teleconsultation to assess the study criteria through different questionnaires during 12 months. Ventilation machines make it possible to carry out remote monitoring, with the help of healthcare providers.

Group Type: EXPERIMENTAL

teleconsultation

Intervention Type: OTHER

Patients will benefit from a quarterly teleconsultation to assess the study criteria through different questionnaires during 12 months.

Interventions

teleconsultation

Patients will benefit from a quarterly teleconsultation to assess the study criteria through different questionnaires during 12 months.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Patient over 18 years,
• Patient with Amyotrophic Lateral Sclerosis (ALS),
• Already fitted by Non Invasive Ventilation (NIV),
• Patient having signed the informed consent
• Patient affiliated to a social security scheme,
• Patient with a correct understanding of the French language,
• Patient with access to an internet connection at home.

For the caregiver:

• Adult person
• Be the patient's primary caregiver
• Have signed the informed consent intended for the caregiver

Exclusion Criteria

• Patient with another cause of chronic respiratory failure: other neuromuscular diseases, Chronic obstructive pulmonary disease (COPD), diffuse interstitial lung disease,
• Patient under guardianship or under judicial protection,
• Patient dependent at least 20 hours out of 24 of the non invasive Ventilation (NIV).

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University Hospital, Toulouse

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Sandrine Pontier-Marchandise, MD

Role: PRINCIPAL_INVESTIGATOR

University Hopsital Toulouse

Locations

Toulouse University Hospital

Toulouse, , France

Countries

France

Other Identifiers

RC31/20/0477

Identifier Type: -

Identifier Source: org_study_id